Evidence map›Paper›PMID 29330481›Full record

ArticleScientific reports2018

FDXR is a biomarker of radiation exposure in vivo.

Gráinne O'Brien, Lourdes Cruz-Garcia, Matthäus Majewski, Jakub Grepl, Michael Abend, Matthias Port, Aleš Tichý, Igor Sirak, Andrea Malkova, Ellen Donovan and 18 more

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 1 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 1 synthesis or guideline pooled it, 118 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Transcriptomics for radiation biodosimetry: progress and challenges.International journal of radiation biology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

28 authors at 10 institutions in 5 countries.

Gráinne O'BrienCentre for Radiation, Chemical and Environmental Hazards, Public Health England, Oxfordshire, United Kingdom.
Lourdes Cruz-GarciaCentre for Radiation, Chemical and Environmental Hazards, Public Health England, Oxfordshire, United Kingdom.
Matthäus MajewskiBundeswehr Institute of Radiobiology, Munich, Germany.
Jakub GreplDepartment of Radiobiology, Faculty of Military Health Sciences in Hradec Králové, University of Defence in Brno, Hradec Králové, Czech Republic.
Michael AbendBundeswehr Institute of Radiobiology, Munich, Germany.
Matthias PortBundeswehr Institute of Radiobiology, Munich, Germany.
Aleš TichýDepartment of Radiobiology, Faculty of Military Health Sciences in Hradec Králové, University of Defence in Brno, Hradec Králové, Czech Republic.
Igor SirakDepartment of Oncology & Radiotherapy and 4th Department of Internal Medicine - Hematology, University Hospital, Hradec Králové, Czech Republic.
Andrea MalkovaDepartment of Hygiene and Preventive Medicine, Faculty of Medicine in Hradec Králové, Charles University, Hradec Králové, Czech Republic.ORCID http://orcid.org/0000-0001-9444-8065
Ellen DonovanCentre for Vision, Speech and Signal Processing, University of Surrey, Guildford, GU2 7TE, United Kingdom.
Lone GothardInstitute of Cancer Research/Royal Marsden NHS Foundation Trust, Downs Road, Sutton, SM2 5PT, United Kingdom.
Sue BoyleInstitute of Cancer Research/Royal Marsden NHS Foundation Trust, Downs Road, Sutton, SM2 5PT, United Kingdom.
Navita SomaiahInstitute of Cancer Research/Royal Marsden NHS Foundation Trust, Downs Road, Sutton, SM2 5PT, United Kingdom.
Elizabeth AinsburyCentre for Radiation, Chemical and Environmental Hazards, Public Health England, Oxfordshire, United Kingdom.
Lucyna PongeMaria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland.
Krzysztof SlosarekMaria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland.
Leszek MiszczykMaria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland.
Piotr WidlakMaria Sklodowska-Curie Institute - Oncology Center, Gliwice Branch, Gliwice, Poland.
Edward GreenDepartment of Radiology, Churchill Hospital, Oxford, United Kingdom.
Neel PatelDepartment of Radiology, Churchill Hospital, Oxford, United Kingdom.ORCID http://orcid.org/0000-0002-7412-5493
Mahesh KudariDepartment of Radiology, Churchill Hospital, Oxford, United Kingdom.
Fergus GleesonDepartment of Radiology, Churchill Hospital, Oxford, United Kingdom.
Volodymyr VinnikovGrigoriev Institute for Medical Radiology, National Academy of Medical Science, Kharkiv, Ukraine.
Viktor StarenkiyGrigoriev Institute for Medical Radiology, National Academy of Medical Science, Kharkiv, Ukraine.
Sergii ArtiukhGrigoriev Institute for Medical Radiology, National Academy of Medical Science, Kharkiv, Ukraine.
Leonid VasylievGrigoriev Institute for Medical Radiology, National Academy of Medical Science, Kharkiv, Ukraine.
Azfar ZamanDepartment of Cardiology, Freeman Hospital and Institute of Cellular Medicine, Newcastle University, Newcastle-upon-Tyne, Newcastle, United Kingdom.ORCID http://orcid.org/0000-0003-4891-8892
Christophe BadieCentre for Radiation, Chemical and Environmental Hazards, Public Health England, Oxfordshire, United Kingdom. christophe.badie@phe.gov.uk.ORCID http://orcid.org/0000-0003-4572-5008
Churchill Hospital · GBPublic Health England · GBState Organization «Grigoriev Institute for Medical Radiology and Oncology of the National Academy of Medical Sciences of Ukraine»The Maria Sklodowska-Curie National Research Institute of Oncology · PLBundeswehr Medical Service Academy · DERoyal Marsden NHS Foundation Trust · GBUniversity Hospital Hradec Králové · CZCharles University · CZFreeman Hospital · GBUniversity of Surrey · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Previous investigations in gene expression changes in blood after radiation exposure have highlighted its potential to provide biomarkers of exposure. Here, FDXR transcriptional changes in blood were investigated in humans undergoing a range of external radiation exposure procedures covering several orders of magnitude (cardiac fluoroscopy, diagnostic computed tomography (CT)) and treatments (total body and local radiotherapy). Moreover, a method was developed to assess the dose to the blood using physical exposure parameters. FDXR expression was significantly up-regulated 24 hr after radiotherapy in most patients and continuously during the fractionated treatment. Significance was reached even after diagnostic CT 2 hours post-exposure. We further showed that no significant differences in expression were found between ex vivo and in vivo samples from the same patients. Moreover, potential confounding factors such as gender, infection status and anti-oxidants only affect moderately FDXR transcription. Finally, we provided a first in vivo dose-response showing dose-dependency even for very low doses or partial body exposure showing good correlation between physically and biologically assessed doses. In conclusion, we report the remarkable responsiveness of FDXR to ionising radiation at the transcriptional level which, when measured in the right time window, provides accurate in vivo dose estimates.

Indexed as

Whole-Body IrradiationAdultAgedAged, 80 and overBiomarkersCurcuminFemaleFerredoxin-NADP ReductaseHumansLipopolysaccharidesMaleMiddle AgedNeoplasmsRNATomography, X-Ray ComputedUp-RegulationBiomarkersCurcuminFerredoxin-NADP ReductaseLipopolysaccharidesRNA

Identifiers

PMID29330481
PMCPMC5766591
OpenAlexW2783600734

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.